Swedish Pharmaceuticals & Biotech High Growth Potential Companies

Camurus

Market Cap: SEK 37.1b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bonesupport Holding

Market Cap: SEK 13.3b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Egetis Therapeutics

Market Cap: SEK 2.3b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Biovica International

Market Cap: SEK 159.7m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

Ascelia Pharma

Market Cap: SEK 363.3m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Initiator Pharma

Market Cap: SEK 190.3m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Xspray Pharma

Market Cap: SEK 1.1b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Corline Biomedical

Market Cap: SEK 484.9m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Lipigon Pharmaceuticals

Market Cap: SEK 59.3m

Develops drugs for lipid related diseases in Sweden.

Genovis AB (publ.)

Market Cap: SEK 1.4b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

IDL Diagnostics

Market Cap: SEK 102.3m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.8b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Xbrane Biopharma

Market Cap: SEK 207.3m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 123.0m

A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.

Diamyd Medical

Market Cap: SEK 1.3b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

BioInvent International

Market Cap: SEK 2.0b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Active Biotech

Market Cap: SEK 95.1m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

SynAct Pharma

Market Cap: SEK 1.1b

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

BioGaia

Market Cap: SEK 10.5b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Hansa Biopharma

Market Cap: SEK 2.7b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

IRLAB Therapeutics

Market Cap: SEK 192.8m

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.

Oncopeptides

Market Cap: SEK 1.4b

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

Moberg Pharma

Market Cap: SEK 413.6m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

AlzeCure Pharma

Market Cap: SEK 244.8m

Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

Guard Therapeutics International

Market Cap: SEK 27.1m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Lipum

Market Cap: SEK 250.3m

A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.

Annexin Pharmaceuticals

Market Cap: SEK 179.3m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

AddLife

Market Cap: SEK 22.0b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Vitrolife

Market Cap: SEK 19.4b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Swedencare

Market Cap: SEK 5.6b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Swedish Orphan Biovitrum

Market Cap: SEK 116.1b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Mendus

Market Cap: SEK 287.2m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

FluoGuide

Market Cap: SEK 654.0m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Elicera Therapeutics

Market Cap: SEK 262.1m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

MedCap

Market Cap: SEK 8.0b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.